Xuanzhu Zhao
Tianjin Union Medical Center Of Nankai University, P.R. China
Tianjin, 300121, China
Tianjin, 300121, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Curcumin induces and enhances the PARP1-mediated parthanatos in diffuse large B cell lymphoma.
Journal: Oncology letters
Published: October 24, 2025
β-Sitosterol Inhibits Tumor Growth and Amplifies Rituximab Sensitivity through Acid Sphingomyelinase/Ceramide Signaling in Diffuse Large B-Cell Lymphoma.
Journal: Journal of agricultural and food chemistry
Published: July 11, 2024
Influence of High-Risk Pathological Factors and their Interaction on the Survival Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer: A Retrospective Study.
Journal: Journal of Cancer
Published: February 27, 2024
Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 19, 2022
The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review.
Journal: Expert review of molecular diagnostics
Published: September 16, 2022
Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen.
Journal: Scientific reports
Published: August 23, 2022
The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms.
Journal: Translational cancer research
Published: June 16, 2022
Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods.
Journal: BMC cancer
Published: June 08, 2022
Young Patients With Colorectal Cancer Have Higher Early Mortality but Better Long-Term Survival.
Journal: Clinical and translational gastroenterology
Published: May 03, 2022
FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.
FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.
Journal: Clinical and translational medicine
Published: November 23, 2021
Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review.
Journal: Cancer cell international
Published: October 03, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026